CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.2800
0.00 (0.00%)
Jun 16, 2026, 3:58 PM EST
CytoDyn Market Cap
CytoDyn has a market cap or net worth of $391.12 million as of June 16, 2026. Its market cap has decreased by -9.21% in one year.
Market Cap
391.12M
Enterprise Value
404.29M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.28
Market Cap Chart
Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 391.12M, an increase of 6,963.08%. That is a compound annual growth rate of 22.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 391.12M | 9.98% |
| Dec 31, 2025 | 355.63M | 164.14% |
| Dec 31, 2024 | 134.63M | -29.42% |
| Dec 29, 2023 | 190.74M | 2.63% |
| Dec 30, 2022 | 185.85M | -72.64% |
| Dec 31, 2021 | 679.28M | -78.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glorywin Entertainment Group | 343.05M |
| Northwest Biotherapeutics | 332.49M |
| Silence Therapeutics | 316.00M |
| Vaxart | 135.11M |
| NDT Pharmaceuticals | 106.90M |
| HST Global | 99.00M |
| BioStem Technologies | 72.32M |
| Sangamo Therapeutics | 62.56M |